{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:26:44Z","timestamp":1790526404684,"version":"4.1.0"},"reference-count":23,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.3960\/jslrt.20022","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T22:06:02Z","timestamp":1602108362000},"page":"169-173","source":"Crossref","is-referenced-by-count":2,"title":["An overlapping case of &lt;i&gt;in situ&lt;\/i&gt; mantle cell neoplasia and leukemic non-nodal mantle cell lymphoma"],"prefix":"10.3960","volume":"60","author":[{"given":"Ryota","family":"Matsuoka","sequence":"first","affiliation":[{"name":"Department of Diagnostic Pathology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamiko","family":"Sakata-Yanagimoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai University School of Medicine, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Jares P, Colomer D, Campo E. Molecular pathogenesis of mantle cell lymphoma. J Clin Invest. 2012; 122: 3416-3423.","DOI":"10.1172\/JCI61272"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Be\u00e0 S. Cyclin D1 transcriptional activation in MCL. Blood. 2014; 123: 1979-1980.","DOI":"10.1182\/blood-2014-02-553057"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Martin P, Chadburn A, Christos P <i>et al.<\/i> Outcome of deferred initial therapy in mantle-cell lymphoma. J Clin Oncol. 2009; 27: 1209-1213.","DOI":"10.1200\/JCO.2008.19.6121"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Herrmann A, Hoster E, Zwingers T <i>et al.<\/i> Improvement of overall survival in advanced stage mantle cell lymphoma. J Clin Oncol. 2009; 27: 511-518.","DOI":"10.1200\/JCO.2008.16.8435"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Carvajal-Cuenca A, Sua LF, Silva NM <i>et al.<\/i> In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica. 2012; 97: 270-278.","DOI":"10.3324\/haematol.2011.052621"},{"key":"6","unstructured":"6 Hsu P, Yang T, Sheikh-Fayyaz S <i>et al.<\/i> Mantle cell lymphoma with in situ or mantle zone growth pattern: a study of five cases and review of literature. Int J Clin Exp Pathol. 2014; 7: 1042-1050."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Ye H, Desai A, Zeng D <i>et al.<\/i> Smoldering mantle cell lymphoma. J Exp Clin Cancer Res. 2017; 36: 185.","DOI":"10.1186\/s13046-017-0652-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Adam P, Schiefer AI, Prill S <i>et al.<\/i> Incidence of preclinical manifestations of mantle cell lymphoma and mantle cell lymphoma in situ in reactive lymphoid tissues. Mod Pathol. 2012; 25: 1629-1636.","DOI":"10.1038\/modpathol.2012.117"},{"key":"9","unstructured":"9 Swerdlow S, Campo E, Harris N, et al. WHO Classification of\u00a0Tumours of\u00a0Haematopoietic and Lymphoid Tissues. Revised 4th ed, Lyon, IARC Press. 2017; pp.285-290."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Nodit L, Bahler DW, Jacobs SA, Locker J, Swerdlow SH. Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes. Hum Pathol. 2003; 34: 1030-1034.","DOI":"10.1053\/S0046-8177(03)00410-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Orchard J, Garand R, Davis Z <i>et al.<\/i> A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood. 2003; 101: 4975-4981.","DOI":"10.1182\/blood-2002-06-1864"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Fern\u00e0ndez V, Salamero O, Espinet B <i>et al.<\/i> Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010; 70: 1408-1418.","DOI":"10.1158\/0008-5472.CAN-09-3419"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Royo C, Navarro A, Clot G <i>et al.<\/i> Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease. Leukemia. 2012; 26: 1895-1898.","DOI":"10.1038\/leu.2012.72"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Espinet B, Ferrer A, Bellosillo B <i>et al.<\/i> Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry. Clin Cancer Res. 2014; 20: 1007-1019.","DOI":"10.1158\/1078-0432.CCR-13-1077"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999; 94: 1848-1854.","DOI":"10.1182\/blood.V94.6.1848"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Hadzidimitriou A, Agathangelidis A, Darzentas N <i>et al.<\/i> Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. Blood. 2011; 118: 3088-3095.","DOI":"10.1182\/blood-2011-03-343434"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Hoster E, Dreyling M, Klapper W <i>et al.<\/i> A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood. 2008; 111: 558-565.","DOI":"10.1182\/blood-2007-06-095331"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Ferrer A, Salaverria I, Bosch F <i>et al.<\/i> Leukemic involvement is a common feature in mantle cell lymphoma. Cancer. 2007; 109: 2473-2480.","DOI":"10.1002\/cncr.22715"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Navarro A, Clot G, Royo C <i>et al.<\/i> Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. Cancer Res. 2012; 72: 5307-5316.","DOI":"10.1158\/0008-5472.CAN-12-1615"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Ferrando AA. SOX11 is a mantle cell lymphoma oncogene. Blood. 2013; 121: 2169-2170.","DOI":"10.1182\/blood-2013-02-480418"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Nygren L, Baumgartner-Wennerholm S, Klimkowska M <i>et al.<\/i> Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Blood. 2012; 119: 4215-4223.","DOI":"10.1182\/blood-2011-12-400580"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Mohanty A, Sandoval N, Phan A <i>et al.<\/i> Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma. Blood. 2019; 133: 306-318.","DOI":"10.1182\/blood-2018-05-851667"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Baran-Marszak F, Boukhiar M, Harel S <i>et al.<\/i> Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma. Haematologica. 2010; 95: 1865-1872.","DOI":"10.3324\/haematol.2009.019745"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/60\/4\/60_20022\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T04:33:45Z","timestamp":1608352425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/60\/4\/60_20022\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.20022","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}